Cenezyme Information

Cenezyme Biotechnologies, LLC., was founded in 2014. Cenezyme strives to develop novel solutions for unmet needs in biomedicine and healthcare by a multidisciplinary and collaborative approach. Our mission is to establish rigorous biomedical research as a foundation for development of therapeutics and diagnostics that would have an impact in human health and well being. Our core competence lies in the diverse background of our scientists to produce a concerted effort in research. With technologies licensed from Academia Sinica of Taiwan, we have built an efficient and novel approach in generating nucleotide based protein target recognition methods. Our proprietary development platform enables rapid generation of molecules that detect targets of interest with high specificity and affinity. Together with our patent pending technology for macromolecule biosynthesis, we are currently developing therapeutic and diagnostic applications for hematologic malignancies and other human diseases. Cenezyme is located in the biotech hub of San Diego, California. We have strong collaboration ties with University of California San Diego, The Scripps Research Inistitute, as well as Academia Sinica of Taiwan, with distinguished professors serving as our advisors. These resources combined with our dedicated, diligent team of scientists are what makes Cenezyme unique and capable of delivering breakthrough research in biomedical applications.